APA aipamena

Mizuno, M., Kuno, A., Yano, T., Miki, T., Oshima, H., Sato, T., . . . Miura, T. (2018). Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts. Physiol Rep.

Chicago Style aipamena

Mizuno, Masashi, et al. "Empagliflozin Normalizes the Size and Number of Mitochondria and Prevents Reduction in Mitochondrial Size After Myocardial Infarction in Diabetic Hearts." Physiol Rep 2018.

MLA aipamena

Mizuno, Masashi, et al. "Empagliflozin Normalizes the Size and Number of Mitochondria and Prevents Reduction in Mitochondrial Size After Myocardial Infarction in Diabetic Hearts." Physiol Rep 2018.